ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism

References

• Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, Mohamoud Y, Huyen Y, McBride AA. The papillomavirus episteme: A central resource for papillomavirus sequence data and analysis. Nucleic Acids Res 2013; 41(Database issue):D571-8; PMID:23093593; https://doi.org/10.1093/nar/gks984
   PubMed Web of Science ®Google Scholar
• Schiffman M, Doorbar J, Wentzensen N, de Sanjose S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers 2016; 2:16086; PMID:27905473; https://doi.org/10.1038/nrdp.2016.86
   PubMed Web of Science ®Google Scholar
• zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2(5):342-50; PMID:12044010; https://doi.org/10.1038/nrc798
   PubMed Web of Science ®Google Scholar
• Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Hildesheim A, Morales J, Rydzak G, Schiffmann M. (Proyecto Epidemiologico Guanacaste Group). Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. J Infect Dis 2011; 203(6):814-22; PMID:21343148; https://doi.org/10.1093/infdis/jiq116
   PubMed Web of Science ®Google Scholar
• Bonanni P, Bechini A, Donato R, Capei R, Sacco C, Levi M, Boccalini S. Human papilloma virus vaccination: Impact and recommendations across the world. Ther Adv Vaccines 2015; 3(1):3-12; PMID:25553242; https://doi.org/10.1177/2051013614557476
   PubMedGoogle Scholar
• Garland SM. The Australian experience with the human papillomavirus vaccine. Clin Ther 2014; 36(1):17-23; PMID:24417782; https://doi.org/10.1016/j.clinthera.2013.12.005
   PubMed Web of Science ®Google Scholar
• Khallouf H, Grabowska AK, Riemer AB. Therapeutic vaccine strategies against human papillomavirus. Vaccines (Basel) 2014; 2(2):422-62; PMID:26344626; https://doi.org/10.3390/vaccines2020422
   PubMedGoogle Scholar
• Skeate JG, Woodham AW, Einstein MH, Da Silva DM, Kast WM. Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vacc Immunother 2016; 12(6):1418-29; PMID:26835746; https://doi.org/10.1080/21645515.2015.1136039
   PubMed Web of Science ®Google Scholar
• van der Sluis TC, van der Burg SH, Arens R, Melief CJ. New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer. Curr Opin Immunol 2015; 35:9-14; PMID:26001120; https://doi.org/10.1016/j.coi.2015.05.002
   PubMed Web of Science ®Google Scholar
• Grabowska AK, Riemer AB. The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J 2012; 6:249-56; PMID:23341860; https://doi.org/10.2174/1874357901206010249
   PubMedGoogle Scholar
• Westrich JA, Warren CJ, Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res 2017; 231:21-33; PMID:27890631; https://doi.org/10.1016/j.virusres.2016.11.023
   PubMed Web of Science ®Google Scholar
• van der Burg SH, Arens R, Melief CJ. Immunotherapy for persistent viral infections and associated disease. Trends Immunol 2011; 32(3):97-103; PMID:21227751; https://doi.org/10.1016/j.it.2010.12.006
   PubMed Web of Science ®Google Scholar
• Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. J Immunol 2001; 167(9):5420-8; PMID:11673561; https://doi.org/10.4049/jimmunol.167.9.5420
   PubMed Web of Science ®Google Scholar
• Georgopoulos NT, Proffitt JL, Blair GE. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 2000; 19(42):4930-5; PMID:11039910; https://doi.org/10.1038/sj.onc.1203860
   PubMed Web of Science ®Google Scholar
• Hasim A, Abudula M, Aimiduo R, Ma JQ, Jiao Z, Akula G, Wang T, Abudula A. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women. PLoS One 2012; 7(9):e44952; PMID:23024775; https://doi.org/10.1371/journal.pone.0044952
   PubMed Web of Science ®Google Scholar
• Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008; 57(2):197-206; PMID:17622526; https://doi.org/10.1007/s00262-007-0362-8
   PubMed Web of Science ®Google Scholar
• Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, et al. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res 2005; 65(23):11146-55; PMID:16322265; https://doi.org/10.1158/0008-5472.CAN-05-0772
   PubMed Web of Science ®Google Scholar
• York IA, Brehm MA, Zendzian S, Towne CF, Rock KL. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci U S A 2006; 103(24):9202-7; PMID:16754858; https://doi.org/10.1073/pnas.0603095103
   PubMed Web of Science ®Google Scholar
• York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, Rock KL. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues. Nat Immunol 2002; 3(12):1177-84; PMID:12436110; https://doi.org/10.1038/ni860
   PubMed Web of Science ®Google Scholar
• Keller M, Ebstein F, Burger E, Textoris-Taube K, Gorny X, Urban S, Zhao F, Dannenberg T, Sucker A, Keller C, et al. The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126–35 -specific T-cell recognition. Eur J Immunol 2015; 45(12):3257-68; PMID:26399368; https://doi.org/10.1002/eji.201445243
   PubMed Web of Science ®Google Scholar
• James E, Bailey I, Sugiyarto G, Elliott T. Induction of protective antitumor immunity through attenuation of ERAAP function. J Immunol 2013; 190(11):5839-46; PMID:23610143; https://doi.org/10.4049/jimmunol.1300220
   PubMed Web of Science ®Google Scholar
• Zervoudi E, Saridakis E, Birtley JR, Seregin SS, Reeves E, Kokkala P, Aldhamen YA, Amalfitano A, Mavridis IM, James E, et al. Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses. Proc Natl Acad Sci U S A 2013; 110(49):19890-5; PMID:24248368; https://doi.org/10.1073/pnas.1309781110
   PubMed Web of Science ®Google Scholar
• Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92(2):276-84; PMID:11291057; https://doi.org/10.1002/ijc.1174
   PubMed Web of Science ®Google Scholar
• Chang SC, Momburg F, Bhutani N, Goldberg AL. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a “molecular ruler” mechanism. Proc Natl Acad Sci U S A 2005; 102(47):17107-12; PMID:16286653; https://doi.org/10.1073/pnas.0500721102
   PubMed Web of Science ®Google Scholar
• Hearn A, York IA, Rock KL. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. J Immunol 2009; 183(9):5526-36; PMID:19828632; https://doi.org/10.4049/jimmunol.0803663
   PubMed Web of Science ®Google Scholar
• Stanke J, Hoffmann C, Erben U, von Keyserling H, Stevanovic S, Cichon G, Schneider A, Kaufmann AM. A flow cytometry-based assay to assess minute frequencies of CD8+ T cells by their cytolytic function. J Immunol Methods 2010; 360(1–2):56-65; PMID:20558172; https://doi.org/10.1016/j.jim.2010.06.005
   PubMed Web of Science ®Google Scholar
• Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, Fraioli R, Sibilio L, Carroll O, Hattori A, van Endert PM, et al. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 2006; 176(8):4869-79; PMID:16585582; https://doi.org/10.4049/jimmunol.176.8.4869
   PubMed Web of Science ®Google Scholar
• Fruci D, Giacomini P, Nicotra MR, Forloni M, Fraioli R, Saveanu L, van Endert P, Natali PG. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J Cell Physiol 2008; 216(3):742-9; PMID:18393273; https://doi.org/10.1002/jcp.21454
   PubMed Web of Science ®Google Scholar
• Kamphausen E, Kellert C, Abbas T, Akkad N, Tenzer S, Pawelec G, Schild H, van Endert P, Seliger B. Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma. Cancer Immunol Immunother 2010; 59(8):1273-84; PMID:20419298; https://doi.org/10.1007/s00262-010-0856-7
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science 2015; 347(6220):1260419; PMID:25613900; https://doi.org/10.1126/science.1260419
   PubMed Web of Science ®Google Scholar
• Andres AM, Dennis MY, Kretzschmar WW, Cannons JL, Lee-Lin SQ, Hurle B, Program NCS, Schwartzberg PL, Williamson SH, Bustamante CD, et al. Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet 2010; 6(10):e1001157; PMID:20976248; https://doi.org/10.1371/journal.pgen.1001157
   PubMed Web of Science ®Google Scholar
• Nagarajan NA, de Verteuil DA, Sriranganadane D, Yahyaoui W, Thibault P, Perreault C, Shastri N. ERAAP shapes the peptidome associated with classical and nonclassical MHC class I molecules. J Immunol 2016; 197(4):1035-43; PMID:27371725; https://doi.org/10.4049/jimmunol.1500654
   PubMed Web of Science ®Google Scholar
• Costantino F, Talpin A, Evnouchidou I, Kadi A, Leboime A, Said-Nahal R, Bonilla N, Letourneur F, Leturcq T, Ka Z, et al. ERAP1 gene expression is influenced by nonsynonymous polymorphisms associated with predisposition to spondyloarthritis. Arthritis Rheumatol 2015; 67(6):1525-34; PMID:25740711; https://doi.org/10.1002/art.39072
   PubMed Web of Science ®Google Scholar
• Alvarez-Navarro C, Martin-Esteban A, Barnea E, Admon A, Lopez de Castro JA. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-associated HLA-A*29:02 antigen. Mol Cell Proteomics 2015; 14(7):1770-80; PMID:25892735; https://doi.org/10.1074/mcp.M115.048959
   PubMed Web of Science ®Google Scholar
• Reeves E, Colebatch-Bourn A, Elliott T, Edwards CJ, James E. Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis. Proc Natl Acad Sci U S A 2014; 111(49):17594-9; PMID:25422414; https://doi.org/10.1073/pnas.1408882111
   PubMed Web of Science ®Google Scholar
• Reeves E, Edwards CJ, Elliott T, James E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 2013; 191(1):35-43; PMID:23733883; https://doi.org/10.4049/jimmunol.1300598
   PubMed Web of Science ®Google Scholar
• Guasp P, Alvarez-Navarro C, Gomez-Molina P, Martin-Esteban A, Marcilla M, Barnea E, Admon A, Lopez de Castro JA. The peptidome of Behcet's disease-associated HLA-B*51:01 includes two subpeptidomes differentially shaped by endoplasmic reticulum aminopeptidase 1. Arthritis Rheumatol 2016; 68(2):505-15; PMID:26360328; https://doi.org/10.1002/art.39430
   PubMed Web of Science ®Google Scholar
• Stamogiannos A, Papakyriakou A, Mauvais FX, van Endert P, Stratikos E. Screening identifies thimerosal as a selective inhibitor of endoplasmic reticulum aminopeptidase 1. ACS Med Chem Lett 2016; 7(7):681-5; PMID:27437077; https://doi.org/10.1021/acsmedchemlett.6b00084
   PubMed Web of Science ®Google Scholar
• Castro F, Dirks WG, Fahnrich S, Hotz-Wagenblatt A, Pawlita M, Schmitt M. High-throughput SNP-based authentication of human cell lines. Int J Cancer 2013; 132(2):308-14; PMID:22700458; https://doi.org/10.1002/ijc.27675
   PubMed Web of Science ®Google Scholar
• Schmitt M, Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 2009; 37(18):e119; PMID:19589807; https://doi.org/10.1093/nar/gkp581
   PubMed Web of Science ®Google Scholar
• Riemer AB, Keskin DB, Reinherz EL. Identification and validation of reference genes for expression studies in human keratinocyte cell lines treated with and without interferon-gamma - a method for qRT-PCR reference gene determination. Exp Dermatol 2012; 21(8):625-9; PMID:22775998; https://doi.org/10.1111/j.1600-0625.2012.01537.x
   PubMed Web of Science ®Google Scholar
• Rucevic M, Kourjian G, Boucau J, Blatnik R, Garcia Bertran W, Berberich MJ, Walker BD, Riemer AB, Le Gall S. Analysis of major histocompatibility complex-bound HIV peptides identified from various cell types reveals common nested peptides and novel T cell responses. J Virol 2016; 90(19):8605-20; PMID:27440904; https://doi.org/10.1128/JVI.00599-16
   PubMed Web of Science ®Google Scholar
• Liebig TM, Fiedler A, Zoghi S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon MS. Generation of human CD40-activated B cells. J Vis Exp 2009; 32:pii:1373; PMID:19838159; https://doi.org/10.3791/1373
   PubMedGoogle Scholar